
IFGL Refractories: consol PAT doubles YoY to ₹25.7 Cr, adjusted ~33%, margins expand
IFGL Refractories' consolidated PAT came in at ₹25.7 Cr for Q2 FY27, up ~103% YoY (₹12.7 Cr) and up ~51% QoQ, on consolidated revenue of ₹553.1 Cr (+13.2% YoY, +8.0% QoQ). But the YoY jump flatters the underlying trend: roughly ₹6.7 Cr of the gain comes from goodwill amortisation (from the 2016 IFGL–Monocon merger) running off to nil after March 2026 — a charge the year-ago quarter still carried — and a further chunk from the European subsidiary flipping from a ₹7.36 Cr segment loss a year ago to a ₹0.89 Cr profit this quarter. Stripping these largely non-recurring/structural items out, underlying YoY PAT growth is closer to ~33%, which is the number that should anchor any read of this result — still a genuinely good quarter, not the headline-doubling it first appears. Margins did expand on an operating basis: consolidated OPM (EBITDA/revenue) rose to 8.83% from 7.77% a year ago and 7.22% last quarter, with NPM up to 4.63% from 2.59% YoY. The expansion sits mainly on raw-material and other-expense lines growing slower than revenue, consistent with better overseas mix (America segment result nearly doubled YoY to ₹10.6 Cr from ₹5.6 Cr) layering on top of the amortisation tailwind. Management's own standing guidance — a double-digit consolidated EBITDA margin and double-digit domestic growth by FY27-end — is on track but not yet fully met: domestic (India) revenue grew 12.2% YoY this quarter to ₹319.7 Cr, clearing the double-digit bar, while H1 domestic growth (9.86%) still trails it; margin at 8.83% is improving but short of the double-digit target. No management press release was available to cross-check tone beyond the filing itself, and no verified street/consensus estimate for this print turned up in search, so vs-street is unknown rather than assumed. The standalone (India-only) entity tells a steadier story — PAT up 23.3% YoY to ₹18.3 Cr on revenue up 12.7% to ₹323.3 Cr — underscoring that most of the consolidated beat is an overseas/accounting story, not a domestic acceleration; readers comparing the two sets of numbers should not read the gap as an error. Subsequent to the quarter, the company terminated its JV agreement with Marvels International Group (Seychelles) and Marvel Refractories (Anshan) of China effective October 14, 2026, and charged off ₹1.5–1.7 Cr against the related IFGL-Marvels Refractories investment/capex on prudence grounds pending a valuation change — a modest, flagged item that doesn't affect this quarter's core P&L materially.
Key Highlights
- Consolidated PAT ₹25.7 Cr, +103% YoY reported but ~33% YoY on an adjusted basis (ex goodwill-amortisation runoff and Europe segment turnaround) — the adjusted number is the real read.
- Consolidated revenue ₹553.1 Cr, +13.2% YoY / +8.0% QoQ; India (domestic) revenue +12.2% YoY to ₹319.7 Cr, clearing management's double-digit domestic-growth bar for the quarter.
- OPM expanded to 8.83% (from 7.77% YoY, 7.22% QoQ); NPM to 4.63% (from 2.59% YoY) — improving but still short of the double-digit EBITDA-margin target management has guided to.
- Europe segment swung to a ₹0.89 Cr profit from a ₹7.36 Cr loss a year ago; America segment result nearly doubled YoY to ₹10.6 Cr from ₹5.6 Cr — overseas recovery is the standout driver.
- Standalone (India-only) PAT grew a steadier +23.3% YoY to ₹18.3 Cr on revenue +12.7% to ₹323.3 Cr, versus consolidated's near-doubling — the gap is overseas/accounting-driven, not domestic.
- JV with Marvels International (Seychelles) and Marvel Refractories (China) terminated effective Oct 14, 2026; ₹1.5–1.7 Cr written off against related IFGL-Marvels Refractories carrying value.
- EPS ₹3.57 consolidated (vs ₹2.37 in Q1 FY27, ₹1.76 in Q2 FY26); ₹8.32 Cr tax matter (Sec 10AA appeal) remains an unprovided contingent liability pending Calcutta HC.
Price Impact
More from IFGLEXPOR